For Scientists

Publications

View topic-related background literature as well as publications of the MICROB-PREDICT consortium itself. Once new publications are available, we list them here. Open access listings are linked directly to the full text version. All others lead to the respective journal repository or publisher. For PDFs of our own press releases about progress within the MICROB-PREDICT project please go to DOWNLOADS. To receive our project newsletter please subscribe here!

MICROB-PREDICT Publications

Coming soon!

Background Literature

• Trebicka J, Fernandez J, Papp M et al. (2020)
  ‍The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology.
  Journal of Hepatology, DOI: 10.1016/j.jhep.2020.06.013.
• Alvarez-Silva C, Schierwagen R, Pohlmann A et al. (2019)
  ‍Compartmentalization of Immune Response and Microbial Translocation in Decompensated Cirrhosis.
  Front Immunol. 10: Article number 69.
• Clària J, Moreau R, Fenaille F et al. (2019)
  ‍Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis.
  Hepatology. 69 (4):1686-1701.
• Fernández J, Prado V, Trebicka J et al. (2019)
  ‍Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.
  J. Hepatol. 70 (3):398-411.
• Letunic I, Bork P (2019)
  ‍Interactive Tree Of Life (iTOL) v4: recent updates and new developments.
  Nucleic Acids Res. 47 (1):256-259.
• Niu L, Geyer PE, Wewer Albrechtsen NJ et al. (2019)
  ‍Plasma proteome profiling discrovers novel proteins associated with non-alcoholic fatty liver disease.
  Mol Syst Biol. 15: Article number 8793.
• Quesada-González D, Sena-Torralba A, Wicaksono WP et al. (2019)
  ‍Iridium oxide (IV) nanoparticle-based lateral flow immunoassay.
  Biosens Bioelectron. 132: 132-135.
• Romanov N, Kuhn M, Aebersold R et al. (2019)
  ‍Disentangling Genetic and Environmental Effects on the Proteotypes of Individuals.
  Cell. 177 (5):1308-1318.
• Schmidt TS, Hayward MR, Coelho LP (2019)
  ‍Extensive transmission of microbes along the gastrointestinal tract.
  Elife. 8: Article number 42693.
• Solà E, Solé C, Ginès P (2019)
  ‍New Strategies for the Management of Decompensated Cirrosis: Long-Term Albumin Administration for Everyone?
  Hepatology. 69 (5):2289-2291.
• Trebicka J, Amoros A, Pitarch C et al. (2019)
  ‍Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.
  Front Immunol. 10: Article number 476.
• Schierwagen R, Alvarez-Silva C, Madsen MSA et al. (2018)
  ‍Circulating microbiome in blood of different circulatory compartments.
  Gut. In print
• Schmidt TSB, Raes J, Bork P (2018)
  ‍The human gut microbiome: From association to modulation.
  Cell. 172 (6):1198-1215.
• Trebicka J, Reiberger T, Laleman W (2018)
  ‍Gut-liver axis links portal hypertension to acute-on-chronic liver failure.
  Visc Med. 31 (4):270-275.
• Hackstein CP, Assmus LM, Welz M et al. (2017)
  ‍Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis.
  Gut. 66 (3): 507-518.
• Arroyo V, Moreau R, Patrick S et al. (2016)
  ‍Acute-on-chronic liver failure in cirrhosis
  Nature Reviews Disease Primers. 2: Article number 16041.
• Spinella R, Sawhney R and Jalan R (2016)
  ‍Albumin in chronic liver disease: structure, functions and therapeutic implications.
  Hepatol Int. 10 (1): 124-32.
• Tilg H, Cani PD, Mayer EA (2016)
  ‍Gut microbiome and liver diseases.
  Gut. 65 (12):2035-2044.
• Qin N, Yang F, Li A et al. (2014)
  ‍Alterations of the human gut microbiome in liver cirrhosis.
  Nature. 513 (7516):59-64.
• Moreau R, Jalan R, Gines P et al. (2013)
  ‍Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.
  Gastroenterology. 144 (7):1426-1437.